Vivesto
0.263
SEK
-1.32 %
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 following
-1.32%
-0.19%
+1.35%
-13.65%
-35.58%
+39.78%
-87.45%
-93.6%
-98.55%
www.vivesto.com/en
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VIVE
Daily low / high price
0.26 / 0.27
SEK
Market cap
141.24M SEK
Turnover
54.69K SEK
Volume
207K
Latest videos
Financial calendar
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Per Arwidsson med bolag | 24.8 % | 24.8 % |
| Avanza Pension | 5.7 % | 5.7 % |
| Swedbank Försäkring | 1.5 % | 1.5 % |
| Johan Zetterstedt | 1.5 % | 1.5 % |
| Nordnet Pensionsförsäkring AB | 1.1 % | 1.1 % |
| Mastan AB (Håkan Lagerberg) | 1.0 % | 1.0 % |
| Philip Du Rietz | 0.9 % | 0.9 % |
| Jerry Wiström | 0.9 % | 0.9 % |
| Christer Ericson | 0.7 % | 0.7 % |
| Handelsbanken Liv Försäkring AB | 0.7 % | 0.7 % |
ShowingAll content types
Vivesto signs Apealea option agreement with Zhida Pharmaceutical
Vivesto receives positive Cantrixil preclinical efficacy data
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools